<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Jazz Pharmaceuticals Ireland Limited et al v. RK Pharma, Inc. et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2024cv01028/86797</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2024cv01028/86797/feed" rel="self" type="application/rss+xml" />
        <pubDate>Sat, 11 Jul 2026 16:34:15 -0700</pubDate>
        <lastBuildDate>Sat, 11 Jul 2026 16:34:15 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Jazz Pharmaceuticals Ireland Limited et al v. RK Pharma, Inc. et al - Docket Entries - Showing 1 through 5</description>
                                    <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26866933</guid>
                <pubDate>
            Wed, 18 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Jazz Pharmaceuticals plc for Jazz Pharmaceuticals Ireland Limited filed by Jazz Pharmaceuticals Ireland Limited, Pharma Mar, S.A.. (Attachments: #1 Certificate of Service)(O'Brien, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26866934</guid>
                <pubDate>
            Fri, 13 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,763,615. (mpb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26866937</guid>
                <pubDate>
            Thu, 12 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/13/2024. Date of Expiration of Patent: 12/13/2029.Thirty Month Stay Deadline: 12/15/2027. (mpb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26866938</guid>
                <pubDate>
            Thu, 12 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                DEFICIENCY NOTICE issued by the Court to Plaintiff: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (mpb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26866936</guid>
                <pubDate>
            Thu, 12 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                No Summons Issued. (mpb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26866935</guid>
                <pubDate>
            Thu, 12 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26302989</guid>
                <pubDate>
            Thu, 12 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT for ANDA/PATNENT INFRINGEMENT filed against Apicore US LLC, Archis Pharma LLC, RK Pharma, Inc., Vgyaan Pharmaceuticals LLC ( Filing fee $ 405, receipt number ADEDC-4497204.) - filed by Jazz Pharmaceuticals Ireland Limited, Pharma Mar, S.A.. (Attachments: #1 Civil Cover Sheet #2 Exhibit A)(mpb)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_26302990</guid>
                <pubDate>
            Thu, 12 Sep 2024 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
